Innospec Inc. income statement

In fiscal 2025, Innospec Inc. reported revenue of $1.78bn, down 3.7% on the year before, operating income of $130m (a 7.3% margin) and net income of $117m, or $4.67 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Innospec Inc.: income statement, annual
Fiscal year	2009Dec 2009	2010Dec 2010	2011Dec 2011	2012Dec 2012	2013Dec 2013	2014Dec 2014	2015Dec 2015	2016Dec 2016	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Revenue	599	683	774	776	819	961	1,012	883	1,307	1,477	1,513	1,193	1,483	1,964	1,949	1,845	1,778	1,842
Cost of revenue	—	—	—	—	—	—	—	551	904	1,042	1,047	850	1,049	1,377	1,358	1,303	1,286	1,336
Gross profit	186	214	226	236	255	302	346	332	403	435	466	343	435	587	591	543	492	506
Research and development	16	18	18	20	21	22	25	25	31	33	35	31	37	39	49	57	51	52
Selling, general and administrative	144	114	158	119	142	169	207	217	244	261	281	237	267	361	381	305	285	304
Operating income	21	72	47	97	91	113	156	98	125	134	150	34	132	187	162	178	130	129
Interest expense	6	5	4	2	2	4	2	3	7	7	5	1	0	0	0	0	0	—
Income before tax	18	71	50	93	93	111	152	103	128	132	150	40	134	185	174	41	138	143
Income tax	12	3	3	26	15	27	33	22	66	47	38	11	41	52	35	6	22	21
Net income	6	74	47	67	78	84	120	81	62	85	112	29	93	133	139	36	117	122
Diluted EPS	$0.26	$2.97	$1.92	$2.81	$3.22	$3.38	$4.86	$3.33	$2.52	$3.45	$4.54	$1.16	$3.75	$5.32	$5.56	$1.42	$4.67	$4.89
Diluted shares (average)	25m	25m	25m	24m	24m	25m	25m	24m	24m	25m	25m	25m	25m	25m	25m	25m	25m	25m
EBITDA	39	88	62	108	111	142	192	136	175	183	198	80	175	227	201	221	173	170

US$ millions unless shown otherwise. Fiscal quarters.

Innospec Inc.: income statement, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Revenue	443	467	441	440	442	456	453	491
Cost of revenue	319	331	316	317	325	328	330	353
Gross profit	124	136	125	123	117	127	124	138
Research and development	14	15	13	14	14	11	13	14
Selling, general and administrative	64	79	69	75	72	69	79	84
Operating income	46	41	43	34	6	47	37	40
Income before tax	45	−103	45	32	12	50	40	42
Income tax	11	−32	12	8	−1	3	9	10
Net income	33	−70	33	24	13	47	30	31
Diluted EPS	$1.33	−$2.80	$1.31	$0.94	$0.52	$1.91	$1.22	$1.25
EBITDA	57	52	53	45	18	56	46	50

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: ASH vs IOSP IOSP vs SXT IOSP vs KWR IOSP vs MTX

More: Specialty Chemicals stocks compared, Materials sector, rankings of US companies

Figures from Innospec Inc.'s SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Innospec Inc.